AARTI PHARMALABS
Back to Balance Sheet
|
AARTI PHARMALABS Last 5 Year Contingent Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Contingent Liabilities | ₹14 Cr | ₹7.19 Cr | ₹6.86 Cr | - | - |
What is the latest Contingent Liabilities ratio of AARTI PHARMALABS ?
| Year | Contingent Liabilities |
|---|---|
| Mar2025 | ₹14 Cr |
| Mar2024 | ₹7.19 Cr |
| Mar2023 | ₹6.86 Cr |
| Mar2022 | - |
| Mar2021 | - |
How is Contingent Liabilities of AARTI PHARMALABS Trending?
| Years | Contingent Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹14 Cr | 93.53 | |
| Mar2024 | ₹7.19 Cr | 4.78 | |
| Mar2023 | ₹6.86 Cr | 0 | |
| Mar2022 | - | 0 | |
| Mar2021 | - | - | |
Compare Contingent Liabilities of peers of AARTI PHARMALABS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| AARTI PHARMALABS | ₹6,345.6 Cr | 0.9% | -17% | 11.8% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹439,378.0 Cr | 1.7% | 7.3% | 0% | Stock Analytics | |
| DIVIS LABORATORIES | ₹171,996.0 Cr | 1.8% | 0.9% | 6.1% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹125,959.0 Cr | 1.3% | 4.4% | 14.9% | Stock Analytics | |
| CIPLA | ₹123,666.0 Cr | 0.9% | -2.9% | 1.3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹105,008.0 Cr | 0.5% | -3.1% | 3.3% | Stock Analytics | |
AARTI PHARMALABS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| AARTI PHARMALABS | 0.9% |
-17% |
11.8% |
| SENSEX | 0.6% |
1.3% |
7% |
You may also like the below Video Courses